BridgeBio Pharma Inc (BBIO)
23.24
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 13:31
BridgeBio Pharma Total Assets (Quarterly): 664.98M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 664.98M |
| June 30, 2024 | 794.38M |
| March 31, 2024 | 849.33M |
| December 31, 2023 | 546.38M |
| September 30, 2023 | 655.01M |
| June 30, 2023 | 503.66M |
| March 31, 2023 | 625.68M |
| December 31, 2022 | 623.04M |
| September 30, 2022 | 728.74M |
| June 30, 2022 | 862.23M |
| March 31, 2022 | 813.15M |
| December 31, 2021 | 1.013B |
| Date | Value |
|---|---|
| September 30, 2021 | 781.52M |
| June 30, 2021 | 1.081B |
| March 31, 2021 | 1.093B |
| December 31, 2020 | 703.59M |
| September 30, 2020 | 787.69M |
| June 30, 2020 | 905.23M |
| March 31, 2020 | 989.80M |
| December 31, 2019 | 631.68M |
| September 30, 2019 | 640.53M |
| June 30, 2019 | 325.54M |
| March 31, 2019 | 401.37M |
| December 31, 2018 | 464.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
503.66M
Minimum
Jun 2023
1.093B
Maximum
Mar 2021
782.68M
Average
784.61M
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.205B |
| Pfizer Inc | 219.48B |
| Vertex Pharmaceuticals Inc | 22.24B |
| PTC Therapeutics Inc | 1.842B |
| Bristol-Myers Squibb Co | 93.67B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.883B |
| Shareholders Equity (Quarterly) | -1.230B |
| Debt to Equity Ratio | -1.398 |
| Current Ratio | 3.193 |
| Net Debt Paydown Yield | -0.00% |